Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition
Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition
Oxidative stress can affect the balance of intestinal flora and intestinal structure of
 patients, resulting in intestinal flora disorder. Its bacterial metabolites stimulate the
 parasympathetic nerve, regulate insulin secretion and other metabolic pathways of patients
 through neuroendocrine regulation, resulting in abnormal energy metabolism of lipids and
 sugars in the digestive tract, and finally lead to malnutrition.We hypothesized that fecal
 bacteria transplantation could reconstruct the normal intestinal flora, restore the
 intestinal digestion and absorption function of chronic obstructive pulmonary
 disease（COPD）patients and improve the state of malnutrition.
1. improve the COPD patients with malnutrition is the key to improve the digestion and
 absorption function of chronic obstructive pulmonary disease (COPD) is one of the
 world's third most common cause of death, is characterized by progressive airflow
 limited, mainly by the long-term exposure to tobacco smoke and other harmful air
 pollutants.

 It has been reported that 20%-71% of COPD patients suffer from malnutrition, and there
 is a negative correlation between BMI and prognosis.

 There is increasing evidence that patients with COPD with lower BMI or fat-free mass
 index are associated with poorer prognosis and impaired long-term survival.

 At present, nutrition supplements are mainly used to solve the problem of COPD
 malnutrition, including vitamins and minerals, essential amino acids and biological
 amino acids, anti-inflammatory omega-3, high fat and high carbohydrate, etc., while the
 causes of COPD malnutrition and the relationship between COPD and metabolism have not
 been paid attention to.

 Although there is evidence that there is no malnutrition nutritional support can improve
 the prognosis of patients with COPD, but exist in patients with malnutrition, due to
 impaired digestion and absorption, increase nutrition supply, prone to patients with
 abdominal distension, vomiting, and diarrhea.

 Therefore, in order to improve malnutrition in patients with COPD, it is necessary to
 improve digestion and absorption function in patients with COPD.

 2. improve digestion and absorption function, first of all, correct the oxidative stress
 caused by intestinal flora disorder as part of the systemic oxidative stress response,
 copd patients with intestinal oxidative stress, oxidative stress result of active oxygen
 free radicals on colon epithelium mucosa layer of mucin, lead to the loss of protein,
 mucous layer thickness can be reduced to 50%, resulting in changes in the structure of
 intestinal tract; In addition, under the action of active oxygen free radicals,
 epithelial cells of the digestive tract, the close connection between protein oxidation
 lead to intestinal epithelial permeability enhancement, on the one hand, the intestinal
 toxins can after connection into the intestinal permeability increased cells, affect the
 digestion and absorption function of intestinal cells, on the other hand, the oxidative
 stress products into the lumen of blood, lead to bacterial flora disorder, further
 affect intestinal digestion and absorption of food.

 The common clinical manifestations of intestinal flora disorder are: mild abdominal
 distension, diarrhea, nausea, vomiting, water and electrolyte disturbance,
 hypoproteinemia, malnutrition, and even shock. Therefore, in order to improve intestinal
 digestion and absorption function, it is necessary to correct intestinal flora disorder
 caused by oxidative stress.

 3. intestinal flora and the relationship between nutrition, immunity, metabolism,
 neuroendocrine, normal human intestinal bacteria number, up to about 1013 ~ 1014
 microbes, equivalent to 10 times of the total number of human tissue cells and its
 metabolites other tissue cells function to human body impact, the total number of genes
 at the same time, the intestinal bacteria coding is about more than 100 times of the
 total number of human genes, some experts believe that intestinal flora is one of the
 normal function of the human body organ, the abnormal organs, inevitably affects the
 health of human body.

 Intestinal flora by helping to break down food and absorb nutrition, synthesis of nutrients,
 metabolites indirectly stimulate the nerve endocrine effects such as the host's nutritional
 status: promote ingested B vitamins (B3, B5, B6, B12) and other micronutrients, help absorb
 minerals (calcium, magnesium and iron, etc.), regulating metabolism of glucose and lipid
 storage.

 Synthesis of micronutrients such as vitamin K, B12, biotin, folic acid and pantothenates; By
 affecting the integrity of mucosal epithelium, it plays an immune defense role.

 Intestinal flora disturbance is related to the formation of metabolic diseases such as
 obesity and diabetes in the host. Rachels study showed that intestinal flora disturbance in
 rats can increase the production of acetate, and feeding acetate to rats can promote the
 secretion of insulin in rats, the mechanism of which is realized by the activation of acetate
 through the parasympathetic nerve.

 The production of acetate increases, and the stimulation intensity of parasympathetic nerve
 is enhanced, which promotes insulin secretion, and promotes ghrelin secretion by consuming
 glucose and reducing hypoglycemia, leading to obesity.

 A recent study also showed that the intestinal microbiome shifted from lean donors to
 patients with metabolic syndrome, resulting in increased insulin sensitivity of the
 receptors.4) animal models and patients with copd, there exist dysbacteriosis.
Inclusion Criteria:

 1. Clinical diagnosis of COPD

 2. Tobacco use: current or former smokers with a continuous smoking history of more than
 1 year.

 3. Subjects are willing and able to complete the follow-up according to the plan.

 4. Subjects can cooperate to complete relevant examination items.

 5. Compliance: Subjects must be willing to return to the hospital and complete all visits
 and evaluations according to the protocol.

 Exclusion Criteria:

 1. Having a significant disease or condition other than COPD that, in the Investigator's
 judgment, would put the subject at risk for participating in the study or affect the
 study outcome and the subject's ability to participate in the study.

 2. Women who are pregnant or breastfeeding or who plan to become pregnant during the
 study period.

 3. Digestive system: ① patients with known gastrointestinal organic diseases.

 ② Complicated with intestinal double infection, such as Clostridium difficile
 infection, EHEC, Salmonella, Shigella, Campylobacter, plague and cytomegalovirus;

 ③ patients with various acute infections, tumors, severe arrhythmias, mental
 disorders, drug or alcohol addiction; (4) pregnant or lactating women; (5) Use of
 antibiotics or probiotics within the last 4 weeks; (6) There are taboo witnesses for
 this study; (7) Clinical investigators who were conducting other related COPD studies
 at the time of enrollment or within 3 months before enrollment;

 4. Complicated with serious primary diseases of heart, liver, kidney, hematopoietic
 system and other important organs or systems.

 5. Patients with lower back, chest and abdomen injuries or after surgery.

 6. People with mental disorder or cognitive impairment.

 7. Non-compliance: Subjects did not follow the study procedures, including non-compliance
 to complete the journal.

 8. Informed consent validity is in doubt: Subjects with a history of psychosis, mental
 retardation, poor motivation, substance abuse (including drugs and alcohol), or other
 medical conditions that limit the effectiveness of informed consent in this study.

 9. Obesity (BMI≥28) Hyperlipidemia (1.5 times the upper limit of normal value of plasma
 total cholesterol > or 1.5 times the upper limit of normal value of triglyceride BBB>;
 Confirmed diabetic patients; Diagnosed cancer patients; Have used any antibiotics or
 antibiotics in the last 2 weeks.